Vitiligo is an acquired pigmentary disorder of unknown etiology that is clinically
characterized by the development of white macules related to the selective loss of …

Vitiligo is a multifactorial polygenic disorder with a complex pathogenesis, linked with both
genetic and non‐genetic factors. The precise modus operandi for vitiligo pathogenesis has …

Abstract The Food and Drug Administration (FDA) has authorized Ruxolitinib (Opzelura), as
first at-home treatment for non-segmental vitiligo, an autoimmune condition that causes …

Though vitiligo is one of the psychodermatological disorders which do not cause direct
physical impairment, it is cosmetically disfiguring leading to serious psychological problems …

Abstract Tumor Necrosis Factor (TNF)-α, is a paracrine inhibitor of melanocytes, which plays
a critical role in the pathogenesis of several autoimmune diseases including vitiligo, as …

Vitiligo is an acquired skin disease, characterized by white areas on the skin due to loss of
functional melanocytes. The pathogenesis of the disease is still unclear. Published data …

Background Vitiligo is a depigmenting disorder resulting from loss of functional melanocytes
in the skin. NPY plays an important role in induction of immune response by acting on a …

Interferon-gamma (IFN-γ) is a paracrine inhibitor of melanocytes and genetic variability due
to intron 1 polymorphisms in IFNG has been reported to be associated with increased risk for …

Background Vitiligo is an acquired pigmentary disorder resulting from loss of melanocytes.
Interleukin (IL)‐4 has been shown to stimulate B‐cell proliferation, to regulate …

Background and Objectives. Cytokines regulate immune response and inflammation and
play a crucial role in depigmentation process of vitiligo. The present study aimed to estimate …